Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
05/2002
05/08/2002EP1203000A1 Method for the production of phosphonomethylglycin
05/08/2002EP1202999A1 Novel 2-decarboxy-2-phosphinico prostaglandin f analogs
05/08/2002EP1202998A1 Synthesis of stable quinone and photoreactive ketone phosphoramidite reagents for solid phase synthesis of photoreactive-oligomer conjugates
05/08/2002EP0998479B1 Triazoline-thion-phosphoric acid derivatives
05/08/2002EP0923585B1 Phosphinate based inhibitors of matrix metalloproteases
05/08/2002EP0888365B1 A process for the preparation of diphosphonate derivatives
05/08/2002DE10054218A1 Verfahren zur Herstellung von Alkenylphosphonsäure-Derivaten A process for preparing alkenylphosphonic acid derivatives
05/08/2002DE10053272A1 Neue Bisphosphitverbindungen und deren Metallkomplexe New Bisphosphitverbindungen and their metal complexes
05/08/2002CN1348488A Non-symmetric, partially fluorinated lubricant additives
05/08/2002CN1348457A Production of phosphonopyrazoles
05/08/2002CN1348433A Halogenation of protected phenols in meta position
05/08/2002CN1348375A Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation
05/08/2002CN1347884A Vinyl-pyrrolidone cynnematin with alkali subtituent
05/08/2002CN1347883A Vinyl-pyrrolidone cynnematin with alkali subtituent
05/08/2002CN1347882A Vinyl-pyrrolidone cynnematin with alkali subtituent
05/08/2002CN1347881A 法呢基蛋白转移酶抑制剂 Farnesyl protein transferase inhibitor
05/08/2002CN1347695A Nucleotide analogue composition
05/08/2002CN1084330C Cydic amide derivatives
05/07/2002US6384261 Treating endothelin-mediated disorders; inhibitory binding of endothilin peptides to eta and/or etb receptors; elucidating the physiological and pathophysiological roles and isolating endothelin receptors; antagonists
05/07/2002US6384260 Analogues of phosphatidylinositol-phosphates such as 1d-3,6-di-o-benzyl-myo-inositol as research reagents, structure- and mechanism-based competitive inhibitors; reporter or anchoring groups; chemical intermediates
05/07/2002US6384253 Composite materials
05/07/2002US6384075 Treating diseases in which mast cell dysfunction is involved
05/07/2002US6384041 Bicyclic sPLA2 inhibitors
05/07/2002US6384022 Enzyme inhibitors
05/07/2002US6383490 Drug abuse or dependance
05/07/2002CA2098612C Arthropodicidal carboxanilides
05/02/2002WO2002034759A1 Bridged ylide group containing metal complexes
05/02/2002WO2002034757A2 Production of metal chalcogenide nanoparticles
05/02/2002WO2002034756A2 Beta-substituted beta-aminoethyl phosphonates
05/02/2002WO2002034389A2 Dendritic macromolecules for metal-ligand catalyzed processes
05/02/2002WO2002034204A2 Calcilytic compounds
05/02/2002WO2002014558A3 New hydrazide building blocks and hydrazide modified biomolecules
05/02/2002WO2002011737A3 Anti-inflammatory medicament
05/02/2002WO2002000574A3 Catalysis using phosphine oxide and sulfoxide compounds
05/02/2002WO2001002423A9 2'-guanidinyl-substituted oligonucleotides and gene expression modulation therewith
05/02/2002US20020052721 Data driven layout engine
05/02/2002US20020052527 Novel process for preparing alendronic acid
05/02/2002US20020052521 Enantiomerically enriched; starting from an optically-enriched trihaloiminophosphorane
05/02/2002US20020052492 Process for the production of 2-halo-6-aminopurine derivatives
05/02/2002US20020052364 Condensed 2,3-benzodiazepine derivatives and their use as AMPA-receptor inhibitors
05/02/2002US20020052348 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
05/02/2002US20020052347 Protein tyrosine phosphatase 1B (PTP-1B) inhibitors containing two ortho-substituted aromatic phosphonates
05/02/2002US20020052346 Phosphonic acid biaryl derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)
05/02/2002US20020052345 Novel prodrugs for phosphorus-containing compounds
05/02/2002US20020052344 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase IB (PTP-IB)
05/02/2002US20020052342 Lipophilic cation covalently coupled to an antioxidant moiety, especially compounds, containing a triphenyl phosphonium cation
05/02/2002US20020052337 Composition and method for inhibiting platelet aggregation
05/02/2002US20020050587 Optical material
05/02/2002EP1201737A2 Process for purifying vegetable oil
05/02/2002EP1201714A1 Flame retardant thermoplastic resin composition
05/02/2002EP1201675A1 Bisphosphites and Metal Complexes thereof
05/02/2002EP1201674A1 Process for preparing (dialkylphosphono)alkyl (meth)acrylate
05/02/2002EP1201673A1 Bidentate organophosphorous ligands and their use in catalysis
05/02/2002EP1201650A2 Ionic malonitril derivatives and their uses
05/02/2002EP1200628A2 Attachment of oligonucleotides to solid supports through schiff base type linkages for capture and detection of nucleic acids
05/02/2002EP1200455A1 Enzyme catalyzed therapeutic activation
05/02/2002EP1200452A1 Novel chiral phosphorus ligands and the use thereof in the production of optically active products
05/02/2002EP1200451A1 Radiolabelled bisphosphonates and method
05/02/2002EP1200450A1 Method for the production of phosphonomethylglycine
05/02/2002EP1200437A1 Method for producing by stereospecific hydration tetrahydropterins and optically pure derivatives, in particular tetrahydrofolic acid and its optically pure derivatives
05/02/2002EP1200427A2 Small molecule modulators of g protein-coupled receptor six (gpr6)
05/02/2002EP1200345A1 Method of preparation for silica (sio 2?) from rice bran
05/02/2002EP1199933A1 Process for making a downstream processable ammonium glyphosate paste
05/02/2002EP1199932A1 Process for making ammonium glyphosate flakes
05/02/2002EP1199927A1 Process for making ammonium glyphosate powder
05/02/2002EP0742224B1 Process for producing organophosphorus ester compound and reactive flame retardant
05/02/2002DE10052462A1 New diaryl-anellated bicyclo phosphorus, arsenic and antimony compounds are used as hydroformylation, hydrocyanation, carbonylization, hydrogenation, polymerization or metathesis catalyst or ligand in metal complex catalyst
05/02/2002DE10052391A1 New bidentate organophosphorus ligands with a chiral carbon center, used in complex compounds for use as catalysts in asymmetric reactions or polymerizations, especially asymmetric hydroformylation or hydrogenation
05/02/2002CA2426773A1 Beta-substituted beta-aminoethyl phosphonates
05/02/2002CA2426758A1 Bridged ylide group containing metal complexes
05/01/2002CN1347460A Monolayer and electrode for detecting label-bearing target and method of use thereof
05/01/2002CN1347423A Catalyst contg. N-pyrrolyl substd. nitrogen donors
05/01/2002CN1347318A Inhibitors of IMPDH enzyme
05/01/2002CN1083845C Method for mfg. ascorbyl monophosphates
05/01/2002CN1083842C [1,2,4] triazolo [4,3-a] quinoxalinone derivs., their preparation and use
04/2002
04/30/2002USRE37686 Biosynthesis of polypeptides
04/30/2002US6380439 Using catalyst mixture containing molybdenum compound
04/30/2002US6380421 Hydrocyanation process
04/30/2002US6380416 Chiral bidentate phosphine ligands with cyclic rings to restrict conformational flexibility of the ligands to enhance efficiency; stereoselective hydrogenation of ketones to alcohols, and a-acetoamidocinnamic acid to acylamino acids
04/30/2002US6380412 Optically active diphosphines, preparation thereof according to a process for the resolution of the racemic mixture and use thereof
04/30/2002US6380393 Complex containing pyrazole ring
04/30/2002US6380392 Complexes
04/30/2002US6380328 Catalyst systems and their use in a polymerization process
04/30/2002US6380241 For therapy of coronary angina, cerebral vasospasm, acute and chronic renal failure, gastric ulceration, cyclosporin-induced nephrotoxicity, endotoxin-induced toxicity, asthma, lpl-related lipoprotein disorders, proliferative diseases
04/30/2002US6380211 For treating diabetes
04/30/2002US6380175 Method for enhancement of delivery of THC by the administration of its prodrugs via the nasal route
04/30/2002US6380139 Bisdithiophosphoric acid derivatives as lubricant additives
04/30/2002US6379748 Tantalum amide precursors for deposition of tantalum nitride on a substrate
04/30/2002US6379698 Fusogenic lipids and vesicles
04/30/2002CA2221417C Anhydrous alendronate monosodium salt formulations
04/30/2002CA2088931C Phosphonooxy and carbonate derivatives of taxol
04/25/2002WO2002032911A1 Method for producing phosphoric acid esters
04/25/2002WO2002032910A1 Method for producing phosphoric acid esters
04/25/2002WO2002032392A1 Skin pore minimizers and skin elasticity improvers
04/25/2002WO2001083740A3 Splice-region antisense composition and method
04/25/2002WO2001077054A3 Process and catalyst for dehydrogenating primary alcohols to make carboxylic acid salts
04/25/2002US20020049355 Process for producing aldehyde
04/25/2002US20020049336 Water soluble prodrugs of azole compounds
04/25/2002US20020049334 Water soluble prodrugs of azole compounds
04/25/2002US20020049331 Reacting cyclopropylcarboxaldehyde with substituted phosphorylglycine to form enamide which is hydrogenated in presence of transition metal catalyst containing metal and bis-phosphine compound; chemical intermediates